Pharma Co. Clarus Gets OK For Ch. 11 Drug Sale

By Rick Archer · October 26, 2022, 2:09 PM EDT

A Delaware bankruptcy judge on Wednesday approved drug company Clarus Therapeutics' sale of its sole product for $7.25 million in cash and tens of millions in potential future royalties and payments....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

Clarus Therapeutics Holdings, Inc.

Case Number

1:22-bk-10845

Court

Delaware

Nature of Suit

Date Filed

September 05, 2022